Sun X M, Patel D D, Webb J C, Knight B L, Fan L M, Cai H J, Soutar A K
MRC Lipoprotein Team, Hammersmith Hospital, London, UK.
Arterioscler Thromb. 1994 Jan;14(1):85-94. doi: 10.1161/01.atv.14.1.85.
Familial hypercholesterolemia (FH), caused by many different mutations in the low-density lipoprotein (LDL)-receptor gene, invariably leads to severe premature coronary heart disease (CHD) in homozygous individuals. Heterozygous FH patients are less severely affected but are still at increased risk of CHD in most populations. Although FH homozygotes in China are affected similarly to those elsewhere, heterozygotes are not detected in the general population and obligate heterozygotes are often not hypercholesterolemic by Western standards. Mutations in the LDL-receptor genes of 10 homozygous FH patients from the Jiang-su province of China and their heterozygous parents were analyzed. These include one large and two minor deletions and eight point mutations: four are predicted to introduce a premature stop codon, five to result in a single amino acid substitution or deletion, and one to produce a protein with an abnormal cytoplasmic tail. Expression of the mutant LDL-receptor cDNAs in vitro confirmed that these mutations impaired LDL-receptor function and that several would cause a receptor-negative phenotype. Thus, the lack of clinical expression in obligate FH heterozygotes is not due to unusually "mild" mutations in the LDL-receptor gene, and other genetic or environmental factors must therefore be important in determining phenotypic expression.
家族性高胆固醇血症(FH)由低密度脂蛋白(LDL)受体基因的多种不同突变引起,在纯合个体中总会导致严重的早发性冠心病(CHD)。杂合子FH患者受影响程度较轻,但在大多数人群中患冠心病的风险仍然增加。尽管中国的FH纯合子与其他地方的患者受影响情况相似,但在普通人群中未检测到杂合子,而且按照西方标准,必然的杂合子通常没有高胆固醇血症。对来自中国江苏省的10名FH纯合子患者及其杂合子父母的LDL受体基因中的突变进行了分析。这些突变包括1个大片段缺失、2个小片段缺失和8个点突变:4个预计会引入提前终止密码子,5个会导致单个氨基酸替代或缺失,1个会产生具有异常细胞质尾的蛋白质。突变型LDL受体cDNA的体外表达证实这些突变损害了LDL受体功能,其中一些会导致受体阴性表型。因此,必然的FH杂合子缺乏临床表型并非由于LDL受体基因存在异常“温和”的突变,所以其他遗传或环境因素在决定表型表达方面必定很重要。